PL326970A1 - Orientation of dosage of drugs and therapeutic agents as well as othe glykozaminoglykanes (gags) - Google Patents

Orientation of dosage of drugs and therapeutic agents as well as othe glykozaminoglykanes (gags)

Info

Publication number
PL326970A1
PL326970A1 PL96326970A PL32697096A PL326970A1 PL 326970 A1 PL326970 A1 PL 326970A1 PL 96326970 A PL96326970 A PL 96326970A PL 32697096 A PL32697096 A PL 32697096A PL 326970 A1 PL326970 A1 PL 326970A1
Authority
PL
Poland
Prior art keywords
glykozaminoglykanes
gags
othe
drugs
dosage
Prior art date
Application number
PL96326970A
Inventor
Stefan Gustafson
Original Assignee
Hyal Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002164260A external-priority patent/CA2164260C/en
Priority claimed from CA 2173037 external-priority patent/CA2173037A1/en
Application filed by Hyal Pharma Corp filed Critical Hyal Pharma Corp
Publication of PL326970A1 publication Critical patent/PL326970A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL96326970A 1995-12-01 1996-11-29 Orientation of dosage of drugs and therapeutic agents as well as othe glykozaminoglykanes (gags) PL326970A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002164260A CA2164260C (en) 1995-12-01 1995-12-01 Targeting of dosages of medicines and therapeutic agents
CA 2173037 CA2173037A1 (en) 1996-03-29 1996-03-29 Targeting of dosages of medicines and therapeutic agents and other glycosaminoglycans (gags)

Publications (1)

Publication Number Publication Date
PL326970A1 true PL326970A1 (en) 1998-11-09

Family

ID=25678243

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96326970A PL326970A1 (en) 1995-12-01 1996-11-29 Orientation of dosage of drugs and therapeutic agents as well as othe glykozaminoglykanes (gags)

Country Status (11)

Country Link
EP (1) EP0869798A1 (en)
JP (1) JP2000513707A (en)
KR (1) KR19990071628A (en)
AU (1) AU727001B2 (en)
BR (1) BR9611671A (en)
HU (1) HUP9901935A3 (en)
IL (1) IL124647A0 (en)
MX (1) MX9804343A (en)
NO (1) NO982441D0 (en)
PL (1) PL326970A1 (en)
WO (1) WO1997020564A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD940054A1 (en) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl SULPHATED POLYSACCHARIDES
DE60036915T2 (en) 1999-01-13 2008-08-07 Alchemia Oncology Pty Ltd., Hawthorn USE OF HYALURONAN FOR THE MANUFACTURE OF A MEDICAMENT FOR INCREASING THE EFFICACY OF CYTOTOXIC DRUGS
US9066919B2 (en) 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
AUPQ879500A0 (en) 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
AU2006274509B2 (en) 2005-07-27 2012-01-19 Alchemia Oncology Pty Limited Therapeutic protocols using hyaluronan
CN101287475B (en) 2005-09-07 2012-11-14 阿尔卡米亚肿瘤学股份有限公司 Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
AUPM714794A0 (en) * 1994-07-29 1994-08-18 International Fluid Separation Pty Limited Separation apparatus and method
EP0778776A1 (en) * 1994-08-30 1997-06-18 Hyal Pharmaceutical Corporation Hyaluronic acid and derivatives for modulation of cellular activity

Also Published As

Publication number Publication date
EP0869798A1 (en) 1998-10-14
IL124647A0 (en) 1998-12-06
WO1997020564A1 (en) 1997-06-12
JP2000513707A (en) 2000-10-17
NO982441L (en) 1998-05-28
AU727001B2 (en) 2000-11-30
BR9611671A (en) 1999-12-28
NO982441D0 (en) 1998-05-28
HUP9901935A2 (en) 1999-11-29
KR19990071628A (en) 1999-09-27
MX9804343A (en) 1998-09-30
HUP9901935A3 (en) 2001-04-28
AU7687896A (en) 1997-06-27

Similar Documents

Publication Publication Date Title
HRP960300B1 (en) Inhaler for administration of blister-packed medicaments
EP0692975A4 (en) Administration of vaso-active agent and therapeutic agent
HUP9900751A3 (en) Stable pharmaceutical forms of administration containing parathormone
NZ508526A (en) Opioid formulations for treating pain
EP0759306A3 (en) Medicine administering apparatus
GB9207363D0 (en) Improved use of b2 bronchodilator drugs
ZA899176B (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment
HUP9902105A3 (en) Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
IL118483A (en) Compounds for use in the preparation of medicaments for inhibiting vascular smooth muscle cell migration and pharmaceutical formulations containing them
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
HUP9702241A3 (en) Use of 2-aminoindan derivatives and pharmaceutical compositions containing them
HUP9900186A3 (en) Use of lamellarin alkaloids in therapy and pharmaceutical compositions containing them
HUP9900147A2 (en) Therapeutic agents and pharmaceutical compositions for treatment of autoimmune diseases
IL125913A0 (en) Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and medicament for the treatment of cardio-vascular diseases
GB9601186D0 (en) Administration of Drugs
ZA967915B (en) Therapeutic administration of hemoglobin in cardiac arrest
IL91356A0 (en) Therapeutic nucleosides,their preparation and pharmaceutical compositions containing them
IL108722A (en) Pharmaceutical compositions containing a combination of cisplatin and tamoxifen for therapy of human cancers
HUP9901935A3 (en) Dosage kit for targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags)
IL117152A0 (en) Substituted benzenesulfonylureas and -thioureas processes for their preparation and use of pharmaceutical preparation based on these compounds and medicaments containing them
PL312563A1 (en) Pharmaceutical immunomodulating and treatment aiding preparation
ZA945892B (en) Microparticles processes for their preparation and their use for the preparation of medicaments
IL117179A0 (en) Substituted benzenesulfonylureas and -thioureas processes for their preparation and use of pharmaceutical preparations based on these compounds and medicaments containing them
GB9304745D0 (en) Use of pharmaceutical formulations
ZA951789B (en) Pharmaceutical materials and methods of administration